Based on the findings of the two families and our review of the published literature, we propose that the ELOVL4-associated disease is characterised by a variable phenotypic expression and, importantly, that SCA34 is associated with clinical ataxia phenotypes irrespective of EK skin lesions. The gene discussed is ELOVL4; the disease is Ataxia.